Salarius Pharmaceuticals Stock Plummets After $7M Offering

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded11 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2197515

Show notes

Salarius Pharmaceuticals stock plummets after announcing a $7 million public offering, priced at $1.50 per share, a significant discount from its previous closing value. The offering includes over 4.6 million shares and pre-funded warrants, managed by Ladenburg Thalmann & Co. The funds will be used for clinical program development, debt repayment, and general corporate needs. The offerings closure depends on Salarius planned business combination with Decoy Therapeutics.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.